Creative Planning’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-100
Closed -$2K 1951
2017
Q2
$2K Buy
+100
New +$16.3K ﹤0.01% 4277
2017
Q1
Sell
-1,100
Closed -$19K 4629
2016
Q4
$19K Buy
1,100
+1,000
+1,000% +$151K ﹤0.01% 3111
2016
Q3
$1K Sell
100
-400
-80% -$67.6K ﹤0.01% 4343
2016
Q2
$3K Hold
500
﹤0.01% 3850
2016
Q1
$4K Hold
500
﹤0.01% 3667
2015
Q4
$9K Hold
500
﹤0.01% 3341
2015
Q3
$5K Buy
+500
New +$78.8K ﹤0.01% 3579

Other funds holding AMGN

Creative Planning's AMGN Position: Q2 2026 in Review

Creative Planning increased its Amgen (AMGN) stake by 4.6% in Q2 2026, buying an estimated $3.85M and bringing the position to 258,171 shares worth $93.5M. The position accounts for 0.05% of the portfolio, ranked #155.

Creative Planning first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Creative Planning held 258,171 shares of Amgen worth $93.5M as of Q2 2026.
  • Creative Planning bought 11,257 Amgen shares in Q2 2026, an estimated $3.85M.
  • Amgen made up 0.05% of Creative Planning's portfolio in Q2 2026, its #155 holding.
  • Creative Planning first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.